DD

Deeksha Dixit

Active Director Director DIN 10378625
DIN 10378625 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Deeksha Dixit

Data last updated:

Deeksha Dixit is a Director at Nsn Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Nsn Pharmaceuticals Private Limited reported revenue of ₹25,000 (FY 2025).

DIN 10378625
Primary Designation Director
Industry Pharma
First Appointment 02 Nov 2023
Oldest Company Age 2 yrs
Largest company Nsn Pharmaceuticals Private Limited · ₹25,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nsn Pharmaceuticals Private Limited U46497UP2023PTC191884
Director02 Nov 20232023₹25,000 (FY 2025)Active

Board colleagues of Deeksha Dixit

NameDINCompanyDesignation
Neeraj Singh10378624Nsn Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nsn Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deeksha Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deeksha Dixit

Deeksha Dixit currently holds 1 directorship: Nsn Pharmaceuticals Private Limited (Director, since 02 Nov 2023, revenue ₹25,000 (FY 2025)).

Deeksha Dixit was first appointed on 02 Nov 2023 as Director at Nsn Pharmaceuticals Private Limited.

The current boards of Deeksha Dixit's companies include Neeraj Singh (Nsn Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available